Covid-19: Three companies to manufacture ventilators

NASA granted licenses to three Indian companies have got licences from to manufacture Covid-19 ventilators for serios patients. These are Alpha Design Technologies, Bharat Forge and Medha Servo Drives, according to space organisation.

The National Aeronautics and Space Administration (NASA) developed the ventilator specifically for coronavirus patients at its Jet Propulsion Laboratory (JLP) in Southern California.
VITAL, the special ventilator has been designed by the JPL engineers in a little over a month and received ‘Emergency Use Authorization’ from the Food and Drug Administration on April 30.

According to the statement of NASA, it offers a simple, affordable option for treating critical patients while freeing up traditional ventilators for those with the most severe COVID-19 symptoms. Its flexible design means it also can be modified for use in field hospitals,

Leon Alkalai, Manager of the JPL Office of Strategic Partnerships said that the “VITAL team is very excited to see their technology licenced. Our hope is to have this technology reach across the world and provide an additional source of solutions to deal with the on-going COVID-19 crisis.”

Its design is modified which uses compressed air and can be deployed by a greater range of hospitals and was recently tested at the UCLA Simulation Center in Los Angeles. A high-fidelity lung simulator tested almost 20 different ventilator settings, representing a number of scenarios that could be seen in critically ill patients in an intensive care unit.

Dr Tisha Wang, Clinical Chief of the UCLA Division of Pulmonary and Critical Care Medicine said that “VITAL performed well in simulation testing with both precise and reproducible results,”

  • Related Posts

    Former Advisor to India’s Union Health Ministry gets Quite a Feather in his Cap

    Dr Rajendra Pratap Gupta gets nominated to advise UN Secretary General Geneva/ New Delhi: Former advisor to Union Health Minister of India JP Nadda in his earlier stint and a…

    IPC releases draft NFI-2026 to promote rational use of medicines

    Ghaziabad:- The Indian Pharmacopoeia Commission (IPC) has taken a significant step toward strengthening public health systems with the draft release of the National Formulary of India (NFI) 2026, a comprehensive…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    After two years, pharma volumes pick up pace

    After two years, pharma volumes pick up pace

    NPPA fixes prices of 39 drugs, raises anti-rabies immunoglobulin rate

    NPPA fixes prices of 39 drugs, raises anti-rabies immunoglobulin rate

    Tambaram police arrest two persons after seizing 1,100 banned tablets, 5 kg ganja

    Tambaram police arrest two persons after seizing 1,100 banned tablets, 5 kg ganja

    Rajasthan Healthcare Crisis: 8 Mothers Die Post-C-Section

    Rajasthan Healthcare Crisis: 8 Mothers Die Post-C-Section

    Steroid cream misuse fuels spurt in fungal infections

    Steroid cream misuse fuels spurt in fungal infections

    Dr Reddy’s delays semaglutide supplies due to API issue

    Dr Reddy’s delays semaglutide supplies due to API issue